Testing effectiveness (Phase 2)Ended earlyNCT01596127
What this trial is testing
Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System
Who this might be right for
LeukemiaLymphoid MalignanciesMetastatic Malignant Neoplasm to the Leptomeninges
M.D. Anderson Cancer Center 4